Teva to proceed with Rimsa breach of contract suit after ruling
An employee of Teva Pharmaceutical Industries stands in its Jerusalem oral solid dosage plant (OSD) December 21, 2011. Israel-based Teva is the world's leading generic drugmaker. REUTERS/Ronen Zvulun (JERUSALEM - Tags: BUSINESS
Reuters: Teva to pay US government $519 million over foreign bribery charges - Dec. 22, 2016 | KyivPost | KyivPost - Ukraine's Global Voice
Teva Prices EpiPen Generic at $300
The logo of Teva Pharmaceutical Industries is seen on a part of their building in Jerusalem December 14, 2017. REUTERS/Ammar Awad Stock Photo - Alamy
A Teva Pharmaceutical Industries building is seen in Jerusalem December 14, 2017. REUTERS/Ammar Awad Stock Photo - Alamy
Teva tries to clear Allergan deal with $2B more in asset sales: Reuters | FiercePharma
AstraZeneca's CEO Soriot to join Israeli drugs company Teva: report By Reuters
Teva Pharma shares sink as sales forecast disappoints market
Levinstein's purchase of Teva's Jerusalem plant in doubt - Globes
Shlomo Yanai, Teva's president and chief executive, speaks to the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly
Teva, Amgen end dispute over generic Cinacalcet HCl tablets By Reuters
Spain's Sabadell expects to hit profitability target a year early | Reuters
/s3.amazonaws.com/arc-authors/reuters/fe8c4b1b-9993-48e0-872b-a2ef82f39805.png "Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters")
Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/G5JWOXLOQZIDLHFUUAR3HXPXEQ.jpg "Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters")
Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters
Teva settles shareholder lawsuit over generic drug | Business Insurance
US court invalidates key TEVA drug patent
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports | Ctech
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
An employee of Teva Pharmaceutical Industries walks in its Jerusalem oral solid dosage plant (OSD) December 21, 2011. Israel-based Teva is the world's leading generic drugmaker. REUTERS/Ronen Zvulun (JERUSALEM - Tags: BUSINESS
Teva Pharmaceutical Industries' Jerusalem oral solid dosage plant (OSD) is seen December 21, 2011. Israel-based Teva is the world's leading generic drugmaker. REUTERS/Ronen Zvulun (JERUSALEM - Tags: BUSINESS DRUGS SOCIETY Stock Photo -
A man walks past the logo of Teva Pharmaceutical Industries at their plant in Jerusalem December 14, 2017. REUTERS/Ammar Awad Stock Photo - Alamy
A sign bearing the logo of Teva Pharmaceutical Industries is seen in its Jerusalem oral solid dosage plant (OSD) December 21, 2011. Israel-based Teva is the world's leading generic drugmaker. REUTERS/Ronen Zvulun (
Teva chief executive Shlomo Yanai speaks during a tour at the company's new distribution centre in
Reuters: U.S. states accuse Teva of price-fixing • Rx|X Consulting
